Company profile for Aquinox Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood cancers. We are dedicated to advancing novel therapeutics that we believe will make a clinically meaningful difference in patients’ lives. Our primary focus is anti-inflammatory product candidates targeting SH2-containing inositol-5'-phosphatase 1, or SHIP1, an enzyme that plays a role in an...
We are a pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood cancers. We are dedicated to advancing novel therapeutics that we believe will make a clinically meaningful difference in patients’ lives. Our primary focus is anti-inflammatory product candidates targeting SH2-containing inositol-5'-phosphatase 1, or SHIP1, an enzyme that plays a role in an important cellular signaling pathway in immune cells, known as the PI3K pathway. Aquinox has a broad intellectual property portfolio and pipeline of drug candidates that activate SHIP1.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
Suite 450 – 887 Great Northern Way Vancouver, BC Canada, V5T 4T5
Telephone
Telephone
+604-629-9223
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Clinical Outsourcing

Clinical Outsourcing

Not Confirmed

envelop Contact Supplier

Clinical Outsourcing

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.business-standard.com/article/companies/sun-pharma-owned-subsidiary-to-acquire-canada-s-aquinox-pharma-for-8-2-mn-120072900712_1.html

BUSINESS-STANDARD
28 Jul 2020
IL-2 player Neoleukin gets a leg up in Aquinox merger
IL-2 player Neoleukin gets a leg up in Aquinox merger

07 Aug 2019

// Amirah Al Idrus FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/il-2-player-neoleukin-gets-a-leg-up-reverse-merger-aquinox

Amirah Al Idrus FIERCE BIOTECH
07 Aug 2019

https://endpts.com/reviral-taps-seth-hetherington-to-guide-upcoming-phiia-incyte-aquinox-execs-move-to-ai-shop-notable-labs/

Amber Tong ENDPTS
01 Mar 2019

https://www.srnnews.com/aquinox-pharmas-bladder-pain-drug-fails-to-meet-study-goal/

M. Mishra SRNNEWS
27 Jul 2018

https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-aqxp/aquinox-pharmaceuticals/news/who-owns-most-of-aquinox-pharmaceuticals-inc-nasdaqaqxp/

SIMPLYWALL
09 Jul 2018

https://globenewswire.com/news-release/2018/08/08/1548727/0/en/Aquinox-Pharmaceuticals-Announces-Second-Quarter-2018-Financial-Results.html

GLOBENEWSWIRE
27 Jun 2018

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty